A number of approaches have been proposed to block the HMGB1/RAGE axis to treat inflammatory diseases such as Alzheimer’s disease, ALI, cardiovascular diseases, osteoarthritis, and others. The gene discussed is HMGB1; the disease is early-onset autosomal dominant Alzheimer disease.